Search - Université de Rennes Access content directly

Filter your results

17 Results
authFullName_s : V. Leroy
Image document

Detailed characterization of aeration in lubricating oils by an ultrasonic approach

Che Zhan , Arnaud Saint-Jalmes , M. Receveur , H. El Bahi , F. Rondelez et al.
Tribology International, 2022, 175, pp.107782. ⟨10.1016/j.triboint.2022.107782⟩
Journal articles hal-03739162v1

P1266 : Human albumin use in cirrhotic patients in France: Results of the national “Albu-live” survey

A. Garioud , J. -F. Cadranel , A. Pauwels , T. Thevenot , A. Louvet et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S833, 2015, ⟨10.1016/S0168-8278(15)31461-6⟩
Conference poster hal-01162774v1

Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme

V. Leroy , C. Hezode , S. Metivier , M. Tateo , F. Conti et al.
Journal of Hepatology, 2016, 64 (2), pp.S829. ⟨10.1016/S0168-8278(16)01622-6⟩
Journal articles hal-03590935v1
Image document

Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

E. Rosenthal , C Fougerou-Leurent , A. Renault , Mp. Carrieri , F. Marcellin et al.
HIV Medicine, 2018, 19 (3), pp.227-237. ⟨10.1111/hiv.12571⟩
Journal articles hal-01740817v1

Propagation of ultrasound in aqueous foams

Imen Ben Salem , Reine-Marie Guillermic , V. Leroy , Arnaud Saint-Jalmes , Benjamin Dollet et al.
EUFOAM conference, Jul 2012, Lisbonne, Portugal
Conference papers hal-00935761v1
Image document

Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation results from the CO23 ANRS CUPILT study

Jerome Dumortier , V. Leroy , C. Duvoux , V. De Lédinghen , C. Francoz et al.
Liver Transplantation, 2016, 22 (10), pp.1367--1378. ⟨10.1002/lt.24505⟩
Journal articles hal-01397762v1
Image document

Outils connectés d’APA et cancer de la prostate : revue de la littérature et retour d’expérience

A. Corbel , V. Leroy , Q. Vesval , A. Rebillard , R Mathieu et al.
Progrès en Urologie, 2022, 32 (13), pp.880-887. ⟨10.1016/j.purol.2022.09.012⟩
Journal articles hal-03886482v1

G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

A. Coilly , C. Fougerou , V. de Ledinghen , P. Houssel-Debry , C. Duvoux et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S236--S237, ⟨10.1016/S0168-8278(15)30103-3⟩
Conference papers hal-01162709v1

O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

J. Dumortier , D. Botta-Fridlund , A. Coilly , V. Leroy , C. Fougerou-Leurent et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S247--S248, ⟨10.1016/S0168-8278(15)30128-8⟩
Conference papers hal-01162706v1

LEDIPASVIR/SOFOSBUVIR IN NS3/4A PROTEASE INHIBITOR-EXPERIENCED SUBJECTS WITH HCV GENOTYPE 1 AND HIV-COINFECTION FINAL RESULTS OF THE ANRS HC31 SOFTRIH STUDY

E. Rosenthal , C. Fougerou-Leurent , A. Renault , E. Teicher , S. Dominguez et al.
Journal of Hepatology, 2016, 64, pp.S764--S764
Journal articles hal-01533344v1

LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program

C. Hezode , V. de Ledinghen , H. Fontaine , F. Zoulim , P. Lebray et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S265--S266, 2015, ⟨10.1016/S0168-8278(15)30159-8⟩
Conference poster hal-01162768v1

Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study

T.M. Antonini , A. Coilly , E. Rossignol , C. Fougerou-Leurent , J. Dumortier et al.
Transplantation, 2018, 102 (1), pp.119-126. ⟨10.1097/TP.0000000000001928⟩
Journal articles hal-01685801v1

LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather

H. Fontaine , C. Hezode , F. Zoulim , D. Samuel , M. Bourlière et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S278, 2015, ⟨10.1016/S0168-8278(15)30182-3⟩
Conference poster hal-01162770v1

Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study

P. Houssel-Debry , C. Duvoux , A. Coilly , C. Fougerou-Leurent , C. Jezequel et al.
Journal of Hepatology, 2016, 64 (2), pp.S144--S145. ⟨10.1016/S0168-8278(16)01652-4⟩
Journal articles hal-01533345v1

Pegylated interferon α-2a triggers NK-cell functionality and specific T-cell responses in patients with chronic HBV infection without HBsAg seroconversion

J.B. Costa , T. Dufeu-Duchesne , V. Leroy , I. Bertucci , M. Bouvier-Alias et al.
PLoS ONE, 2016, 11 (6), pp.e0158297. ⟨10.1371/journal.pone.0158297⟩
Journal articles hal-01427005v1

P0804 : Efficacy of sofosbuvir-based treatment regimens in HIV/HCV co-infected patients after liver transplantation: The ANRS CO23 CUPILT study

T. M. Antonini , A. Coilly , S. Radenne , A. Veislinger , D. Botta-Fridlund et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S635--S636, 2015, ⟨10.1016/S0168-8278(15)31007-2⟩
Conference poster hal-01162778v1

O112 : HBsAg clearance after addition of 48 weeks of pegifn in HBeAg negative CHB patients on nucleos(T)ide therapy with undetectable hbvdna for at least one year: final results from ANRS-HB06 pegan study: multicenter randomized controlled phase III trial

M. Bourlière , P. Rabiega , N. Ganne-Carrie , L. Serfaty , P. Marcellin et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S249, ⟨10.1016/S0168-8278(15)30131-8⟩
Conference papers hal-01162707v1